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brain barrier, (b) no metabolism in the brain, (c) reversible binding so that the tracer clears from the brain in its original form as the concentration in the blood falls toward zero, and (d) a low level of non specific binding in brain (Abadie and Baron 1991) .
In general, the approach has been to record a dynamic set of tomograms, describing the uptake and subsequent washout of the tracer following bo lus injection of the tracer at high and low specific activities. In the case of a low-specific activity study the changing concentrations of unlabeled flu maze nil will result in a changing receptor occu pancy throughout the investigation. Various ap proaches have been proposed to handle this non steady state, for example, by calculating the bound l free ratio of the tracer during a time interval of assumed near-equilibrium, the so-called pseu doequilibrium approach (Pappata et aI., 1988) , or by fitting the nonlinear differential equations resulting from the non-steady state (Blomquist et aI., 1990; Price et al., 1991) . The bolus injection method pro posed by Koeppe et al. (1991) is based on perform ing a single high-specific activity study. In this case the steady state of essentially 0% receptor occu pancy pertains throughout the study. Such a study can, however, give only the BmaJ{/Kn ratio, or bind ing potential (Mintun et al., 1984) .
Recently an approach was proposed that avoids these difficulties (Lassen, 1992) . It is based on bolus injection of tracer with a high specific activity under two conditions: the first, injecting the tracer alone; and the second, injecting the tracer during a con stant infusion of nonradioactive flumazenil. In this way a steady state of receptor binding with nonra dioactive flumazenil is maintained in both studies. The data obtained can be analyzed to give values for Bmax and Kn by noncompartmental as well as by compartmental approaches. In the present study the steady-state principle was applied to normal volunteers using e lC]flumazenil as the tracer for the bolus injection and commercially available non radioactive flumazenil for the continuous infusion.
THEORETICAL CONSIDERATIONS
The basic principle of the steady-state approach is to compare two levels of receptor occupancy, one essentially zero and the other in the middle range of occupancy, by using continuous infusion of unla beled flumazenil (Lassen, 1992) . The free concen tration of unlabeled flumazenil in brain water is es sentially zero throughout the tracer alone study and has the constant value L during the second study. L is also the free concentration of flumazenil in plasma water, as a steady state persists between brain and blood for unlabeled flumazenil throughout the second tracer study. The binding potentials, i.e., the bound / free concentration ratio R in the two studies, R(O) and R(L), can be calculated by inte grating the bound and free concentrations from time o to time infinity. Therefore the basic equations de rived from the Michaelis-Menten relation are
where B(t) and F(t) are the concentrations of tracer bound to the receptor and in the free fluid phase of the brain, respectively. The ratio R(L)/R(O) is the fraction of the receptor sites that are available for tracer binding when the unlabeled ligand is infused at a constant rate. The complement of this ratio, 1
, is the occupancy O(L), or fractional binding of receptor sites, at the free concentration L of flumazenil in brain water.
Equations 1 and 2 can therefore be solved for
or solved for Kn, to give
Inserting this result into Eq. 1 gives (4)
These equations are equivalent to performing a Scatchard plot with two points. f�F(t)dt is the area under the concentration curve of the tracer in brain water. It is the same as the area under the tracer curve in an ultrafiltrate of ar terial or venous blood, as all these areas must be identical according to the equal area theorem of Lassen and Perl (1979) . As we assume that diffusion equilibrium in plasma between free flumazenil in plasma water and flumazenil bound to proteins is maintained at all times, it follows that (6) where f is the equilibrium concentration ratio of tracer in plasma water and in whole plasma, i.e., f = F/Cp. The same relation also holds for nonradio active flumazenil.
f�B(t)dt is the area under the receptor-bound tracer concentration curve in the brain. B(t) is ob tained by subtracting from the total brain concen tration, Cb (t ), the nonreceptor-bound tracer con centration, Cb , nr(t), the sum of tracer in brain water and tracer dissolved in brain proteins and lipids. By integration this gives
the brain V d ' This is defined as the equilibrium con centration ratio of brain and plasma, i.e., Vd = Cb l Cp for a hypothetical study in which radioactive tracer has been infused at a constant concentration for a very long time. The essence of the steady-state approach of Lassen (1992) consists of calculating this same Vd from a study with bolus injection of the tracer. This is possible because of the stimulus response theorem, which is valid for all stationary and linear systems. It states that any concentration ratio at equilibrium in a tracer infusion study must equal the ratio of the time integrals to infinity of the same parameters in the bolus injection study. Hence for the two steady states considered, VctCO ) If the concentration of the nonradioactive ligand is infinitely high, then no receptor sites are available for binding with the radioactive tracer. In this case, therefore, Cb (t ) = Cb , nrCt ) and hence (9 ) Assuming that the tracer dissolves by passive phys ical solution with no saturation characteristics both in brain and in plasma, then Vd (00) is a constant, i.e., independent of the concentration of cold ligand. It is denoted >.. , is, according to its definition, the tracer's non-receptor-bound volume of distribu tion, and has the unit of milliliters of plasma per milliliter of brain. It is the brain plasma partition coefficient, i.e., the ratio of the solubility of the tracer in the two phases. This solubility ratio de pends on the gross chemical composition of both phases, the concentrations of water, proteins, and lipids. These characteristics are practically the same in all gray matter regions. Hence 'X. may be taken to be practically constant from one gray mat ter region to the next and also from one subject to the next. It will be recognized that these concepts form the basis of the classic, freely diffusible inert tracer techniques for measuring blood flow in the brain and in other organs as well. Inserting Eqs. 6-9 into Eq 2 shows that
and correspondingly for R(O),
This allows the basic equations (3-5) to be rewritten in the form of operational equations:
In deriving Eq. 13, use is made off = Ll Cp (L), i.e., that the ratio of the plasma water to the total plasma concentration is the same for "cold" flumazenil as for the radioactive tracer. The units of Kn and Bmax are given by these equations. As Land Cp (L) are expressed as nanomoles per liter, we have the fol lowing:
Kn is measured as namomoles per liter of brain water or, equivalently as nanomoles per liter of plasma water; and
Bmax is measured as nanomoles per liter of brain tissue.
Determination of V d
Following the noncompartmental analysis out lined above, Vd can be calculated by Eq. 8 integrat ing both tissue and plasma time-radioactivity curves using exponential extrapolation for times be yond the end of the observation period. Vd can also be obtained from a compartmental analysis. A sin gle-tissue compartment model is sufficient to de scribe the brain curve of e lC ]flumazenil (Koeppe et aI., 1991) . In this case the total tissue curve is given by where K 1 is the blood-to-brain transfer constant and * denotes the convolution integral. A least-squares fitting of the measured Cb (t ) curve to this expres sion gives Kl and Yd ' Appendix describes a computer simulation evaluat ing the errors involved when regional X. and Ko are assumed to be subject to random variations. The results show that the assumed variations of X. do not result in significant systematic errors. For varia tions in Ko the situation is, however, not the same.
Here the errors promulgate in a nonlinear manner, so that the mean value of the intercept (X.) overes timates the assumed true value. Thereby both Ko and Bmax become underestimated, in particular for regions with a low receptor density (B max)'
MATERIALS AND METHODS

Subjects
Five normal male volunteers aged 22 to 65 years were studied. They were not on any medication and had no evidence of neurological disease. All gave informed con sent. The studies were approved by the Research Ethics Committee of the Royal Postgraduate Medical School, Hammersmith Hospital, London. Permission to adminis ter the radioactive tracer was obtained from the Admin istration of Radioactive Substances Advisory Committee of the United Kingdom.
Scanning procedure
Scans were performed in a high-resolution PET scan ner (EeAT 953b; CTI/Siemens, Knoxville, TN, U.S.A.) with performance characteristics as described by Spinks et al. (1992) . The final image resolution (using a Hanning 0.5 reconstruction filter) for 31 simultaneously acquired slices was 8.0 x 8.0 x 4.3 mm (at full-width half maximum).
Each subject was scanned on two occasions. In four subjects the scans were performed within 2 days of each other, but in one they were 9 months apart. Great care was taken to ensure that the subjects were aligned in the same position for each scan. Subjects were positioned with the glabella-inion line parallel to the detector rings, so that the directly obtained transaxial images were par-allel to the intercommissural line (AC-PC line). To min imize movement artifacts and to facilitate accurate repo sitioning, the subject's head was placed within an indi vidually molded thermoplastic head support.
Prior to scanning, a 22-gauge cannula was inserted into the radial artery after subcutaneous infiltration with 0.5% bupivicaine. Next a 20-min transmission scan, using a retractable 68Ga/68Ge_ring source, was performed so that the subsequent emission scans could be corrected for at tenuation. Each subject then received an intravenous bo lus injection of [llC]flumazenil (340-440 MBq). The tracer was prepared by a modification of the method of Maziere et al. (1984) , performing the llC-methylation in acetone containing sodium hydroxide and the des methyl precursor and using reverse HPLC to isolate the [ I lC]flu mazenil. The mean specific activity was 17, 100 MBq/ ILmol (range, 5,800-25,600) and this means, that the chemical amount of flumazenil per dose of tracer injected was less than 10 ILg.
The first scan was performed after injection of tracer alone. In the second study, an infusion of cold flumazenil was started 2 h before tracer injection. The subject was initially loaded with 0.6 mg over 30 min and thereafter the infusion was continued at 0.6 mg/h until the end of the scan. The plasma concentration of unlabeled flumazenil was measured prior to the start of the infusion and then at 5, 20,40, and 80 and 110 min after injection of the tracer.
This injection protocol was chosen on the basis of two preliminary studies involving constant infusion of unla beled flumazenil and measurement of plasma concentra tion but no tracer injection. The protocol aimed at achiev ing a plasma concentration of about 15 nM corresponding to a plasma water concentration of about 10 nM, as this was the expected level of KD according to the literature.
As it is unimportant to reach that level precisely, we did not adjust the injection protocol according to body weight or estimated lean body mass.
Thirty-three sequential scan frames were collected over 120 min. The duration of the frames was progres sively increased, from 5 s at the start to 10 min at the end of the study. Arterial blood was continuously sampled at a rate of 5 mUmin for the first 10 min and then at 2.5 ml/min for the remainder of the scan. Whole-blood radio activity was measured using an on-line bismuth ger man ate (BGO) detection system. Discrete samples taken 2. 5, 5, 10, 20, 30, 40, 80 , and 110 min after injection were used to calibrate the BGO detector and to derive the me tabolite-corrected plasma curve from the measured whole-blood curve by fitting the metabolic fraction to a single exponential function as described previously (Lam mertsma et al., 1991) , with the exception that no correc tion for "sticking" activity was required, as the degree of sticking of [llC]flumazenil to the polytetrafluoroethylene tubing used in the present study was negligible. Frac tional concentrations of hydrophilic metabolites and of unchanged (lipophilic) [11C]flumazenii were det�rmined by solid-phase extraction of plasma followed by HPLC (Luthra et al., 1993) .
Blood samples taken 5, 20, 40, 80, and 110 min after injection of tracer were used to determine the plasma concentration of unlabeled flumazenil by HPLC. Five hundred microliters of plasma was spiked with 25 ILl of internal standard (Ro 15-6166). The mixture was ex tracted after the addition of 50 ILl of buffer (pH 10.5) and 750 ILl of dichloromethane by vortexing for 10 min and centrifugating for 5 min. The aqueous layer was discarded and the remainder vacuum-evaporated at 37°C. The res idue was reconstituted in 100 ILl of mobile phase (50% methanol in water), and 25 ILl injected onto the HPLC. The linearity for this method in the range of 2-200 ng/ml was acceptable (r > 0.998) and the limit of quantification was 2 ng/ml. Free plasma flu maze nil concentrations were determined in the same way, after separation by ultrafil tration using an Amicon micropartition system at 37°C.
Image analysis
Reconstructed flumazenil images were analyzed with interactive image analysis software (Analyze Version 3.0; Biodynamics Research Unit, Mayo Foundation, Roches ter, MN, U.S.A.) on SPARC 2 workstations (Sun Mi crosystem Inc, Mountain View, CA, U.S.A.).
The AC-PC line was defined on an image of the distri bution of radioactivity integrated from 15 to 120 min (Friston et aI., 1989) . In all subjects pitch and roll relative to this line were within 4°, so reformatting of trans axial scans was unnecessary. Images of the distribution of ra dioactivity integrated for the periods 3-15 and 90-120 min were overlaid as a further check for subject movement during a scan. A library of 157 rectangular regions of interest (ROIs) with an average size of 1.2 x 1.2 x 0.43 cm was adapted to the individual brains by visual inspec tion and with reference to a stereotaxic atlas based on the AC-PC line (Talairach and Tournoux, 19 8 8) . ROIs were placed on the following regions (the number of transaxial planes contributing to each region is shown in parenthe ses): brain stem (5), cerebellum (4), caudate (4), putamen (2), thalamus (3), white matter (3), anterior cingulate gy rus (7), and medial (3) and lateral (7) temporal, prefrontal (10), premotor (8), sensorimotor (6), medial (2) and lateral (4) parietal, medial frontal (3), and primary visual (4) cor tex. Time-activity curves, corrected for the decay of II C, were constructed for individual ROIs and all those be longing to each of the 16 defined anatomical regions were averaged so as to correct for ROI size.
Kinetic analysis
In the noncompartmental analysis, the distribution vol umes Vd were calculated from Eq. 8 using integrals of both the metabolite-corrected plasma curves and the tis sue curves. Since the curves were measured only up to 120 min, they were extrapolated using a single exponen tial obtained from a fit over the interval from 40 to 120 min. The metabolite-corrected arterial plasma curves were also used to fit regional brain time-activity curves to a single-compartment model [see Eq. 14 to obtain values for K I , k2' and, hence, Vd ( = K 1 lk2)] incorporating a pa rameter to correct for the small volume of blood in the brain tissue (Lammertsma et aI., 1991) . The blood volume is a fitted parameter averaging 0.65 mUIOO g over all the studies. The weighing factors for the least-squares anal ysis were based on the total counts per frame, assuming that random noise was determined more by the total counts than by the counts in the actual region, with ap propriate corrections for frame duration and decay. This analysis was repeated after deleting a progressive number of frames from the end of the tissue time-activity curves, to determine the shortest scan duration that yielded reli able results. The l20-min data were also fitted to a two tissue compartment model [see Eq.
(3) of Koeppe et al. (1991) ], which includes the rate constants for transfer of free to bound [l1C]flumazenil in tissue (k3/)' and vice versa (k4). In this case the total distribution volume Vd is given by (K l lk2/) . (1 + k3'lk4)' The F statistics (Hawkins et aI., 19 86 ) was used to determine if the two-tissue com partment model produced significantly better fits than the single-tissue compartment model. U sing the V d values from both the tracer-alone and the cold infusion studies, individual values for A. were ob tained for each normal subject using Eq. 15. The regional values of occupancy, K D , and Bmax were then calculated using Eqs. II to 13.
Pseudoequilibrium calculations
In two subjects, subjects I and 5 (Table 1) , a non steady-state study was performed by injecting as a bolus a mixture of [11C]flumazenil and 2 mg of nonradioactive flumazenil. This low-specific activity study and the cor responding tracer-alone study were analyzed as described by Abadie et al. (1992) using the brain stem as the refer ence region. This method assumes that there are no re ceptors in the reference region and that the nonspecific uptake is the same in reference and target regions. In the present study calculations were performed only for the occupital cortex. The concentrations in occipital cortex and brain stem were calculated as nanomoles per liter of brain tissue from the average count rate over the period from 20 to 50 min after injection, the counting efficiency, and the specific activity.
RESULTS
Calculation of V d
The results of one-and two-tissue compartment fits are compared in Fig. 1 . The agreement of the fits to the experimental data and, therefore, the fit ted values of the total volume of distribution (Vd) were very similar. For all ROls in all studies F sta tistics (Hawkins et aI. , 1986) indicated that the two tissue compartment fit did not improve the quality of the fit significantly compared to the single-tissue compartment fit.
Vd values obtained from single-tissue compart- b Fractional free concentration of flumazenil in plasma water, d eter mined by chemical analysis.
C Average free concentration of flumazenil during infusion. L = Cp(L) ·f · 1,000' M-';M = 303.3 is the molecular weight offlumazenil.
d Average A for all gray matter regions using Eq. IS. e Average occupancy for all gray matter regions using Eq. IS. f Average equilibrium constant for all gray matter regions using Eq. 12. ment fits and integral analyses are compared (Fig.  2) for all defined ROls in one subject (top) and for the occipital cortex alone in all five subjects (bot tom). There was a good correlation in all cases: For all ROIs in each subject the correlation coefficients ranged from 0.96 to 0.99, with slopes ranging from 0.92 to 1.18 and with intercepts ranging from -0.06 to 0.12; for the various gray matter regions across subjects, correlation coefficients ranged from 0.87 to 0.99, with slopes ranging from 0.85 to 1.02 and intercepts from -0.05 to 0.76. For the integral anal ysis, the extrapolated part (i.e., from 120 min to infinity) contributed about 10% to the total integral. In some smaller ROIs this contribution was some times different, due to poor exponential fits to the noisy data at the end of the 2-h period. This resulted in Vd values which deviated from the average rela tionship shown in Fig. 2 .
Stability of the single-tissue compartment fit was tested by deleting a progressive number of frames from the end of the study. Values of Vd obtained from fits over 30, 60, and 90 min were compared with those over the entire study period of 120 min for selected ROls, for both the tracer-alone (Fig. 3 , top) and the infusion (Fig. 3, bottom) studies. For all studies, the results at 60 and 90 min were very similar to those at 120 min. The fitted values of Vd respectively. At the bottom a different symbol is used for each subject, with the higher values corresponding to the tracer alone studies. Note that the tracer-alone values for one subject (subject 1) are somewhat lower than those for the other subjects. with an overall mean value of about 10 ng/ml, cor responding to 33 nM and thus to a plasma water concentration of about 20 nM.
Calculation of A. Figure 5 is an example of a fit (linear regression) for A. based on Eq. 15. In the other four subjects the same curve type was found. The average A. cal culated from the y-axis intercepts was 0.79 ± 0.12 ml of of plasma/ml of brain (see Table l ). In the following calculations the individually determined A. value for each subject was used.
Values of Cp(L) and f
The average whole-plasma concentration of non radioactive flumazenil, obtained by chemical anal ysis of the samples collected during the constant infusion studies, are also listed in Table 1 . In addi tion, the table gives the fractional free concentra- 
Pseudoequilihrium
The kinetic constants calculated from the pseu doequilibrium studies in subjects 1 and 5 are listed in Table 3 , together with the corresponding steady state values. The binding potentials were signifi cantly lower for the pseudoequilibrium approach, but the changes in Bmax and Ko did not show a consistent pattern.
DISCUSSION
The present method is based on the assumption that equilibrium is reached and maintained between receptor and blood for the nonradioactive flumaze nil infused in the second study. This infusion was started with a priming injection, followed by a con stant infusion rate for 2 h before (and during) the tracer study, aiming at establishing a constant plasma concentration for about 1 h before the tracer injection, at a level estimated to result in a receptor occupancy of the order of 50%. The plasma concen tration curves obtained showed that nearly constant levels were reached. The mean transit time t = Vd/ K l determines how rapidly the receptor saturates if the plasma concentration is constant. For the oc cipital cortex, having the longest t and hence the slowest equilibration time, Vd was about 7 ml lml and K l about 0.4 ml/ml lmin. Hence t = 17. 5 min or tlh = 12 min. One hour would therefore suffice to attain about 97% of the equilibrium value in the worst case (longest t). The deviations of the ob served plasma curves from the horizontal levels aimed at was noticeable in only one of the five sub jects. As the results obtained in this case did not differ from those in the others, we felt unjustified in rejecting this observation.
In deriving the basic equations it was assumed that the free chemical concentration of the radioac tive tracer was negligible relative to Ko at all times.
At peak brain uptake, about 10 min after the bolus injection, the total concentration of the tracer in the occipital cortex was about 8% of the injected dose/L of brain. This corresponds to a chemical concentration of the order of 2 nM with the specific activity used. As the bound/free ratio, BmaxlKo ra tio, was about 10, the estimated maximal free con centration of the tracer is about 0.2 nM or <2% of the Ko. This justifies the simplification mentioned but also underlines the necessity of using a rela tively high specific activity of [ ll C]flumazenil to maintain the steady state of the system (constant zero receptor occupancy).
The results of the present study confirmed a pre vious finding (Koeppe et aI., 1991) , that the tissue kinetics of e1C]flumazenil could be described sat isfactorily using a single-tissue compartment model. Adding a second tissue compartment did not im prove the quality of the fits significantly. For com- partmental analysis, the study duration could be re duced to 60 min without significant changes. A 60min study duration is preferable to a 120-min duration for patient comfort and also with respect to the accuracy of the metabolite corrected plasma curve. Measurement of metabolites becomes in creasingly unreliable at later time points. Errors in metabolite measurements might explain the slight deviation of the tails of the fitted curves from ob served datum points (Fig. 1) . It is for this reason that we chose to use the 60-min compartmental Vd values for calculating all results.
Compartmental and integral analysis provided practically the same Vd values, with the data points fitting, almost, lines through the origin (0,0). The spread in integral values tended to be slightly greater, probably due to inaccuracies in the extrap olation. Since the integral analysis cannot be re duced to 60 min, compartmental analysis is the method of choice for keeping the study duration short. It should be noted, however, that the com partmental model necessitates arterial sampling, while with the integral approach venous sampling suffices (Lassen, 1992) . The nonspecific volume of distribution of the tracer'll. , which includes nonspecific binding and simple solution in brain water, was assessed by as suming that it tends to be about the same for differ ent gray matter structures. Using the extrapolation approach, an average X. value of 0.79 ml/min was obtained. Due to the limited spatial resolution and fairly large ROIs used, each gray matter region also contains white matter. Hence it is of interest to note that ViO) and Vd(L) for white matter averaged 1.01 and 0.79 ml lml, respectively. This suggests that X. for white matter is close to the average value we obtained for the gray matter-dominated ROIs. Therefore, the variable admixture of white matter will not result in a marked interregional variance of '11. . This, in turn, means that the assumption of a practically constant X. in all ROIs, is probably es sentially correct and supports our extrapolation ap proach for calculating '11. . The good fit obtained by the linear regression analysis (see Fig. 5 ) implies that the interregional variation in 1/o(L) and thereby also of K D must be small. However, as demonstrated in the Appendix, random variations in K D will give rise to a systematic overestimation of '11. , which, in turn, results in underestimation of re gional K D and Bmax values, in particular in receptor poor regions.
To avoid this bias we considered, as an alterna tive approach, using the brain stem, with its very low receptor density, as a reference region for cal culating '11. . Assuming the same K D for brain stem J Cereb Blood Flow Metab, Vol . 15, No. 1, 1995 and occipital cortex, X. values between 0.5 and 0.6 were obtained in four of the five subjects. But in the fifth subject a negative value of X. was obtained, highlighting the problems associated with using a region as small as the brain stem as a reference region. This approach was therefore abandoned. The white matter was not considered suitable as a reference region either, because it cannot a priori be assumed to have the same x. as the gray matter. An experimental approach for calculating regional X. in a given subject would consist of performing a third tracer study using a constant infusion of a very high concentration of "cold" flumazenil. Such a study would be costly and add to the complexity of the procedure. Moreover, the areas under the regional tracer curves would be small so that errors in their determination would also have to be considered.
Our small series of studies showed normal values of the central Bz receptor ranging from about 60 to 120 nmol lL of brain water, with the highest values in the primary visual cortex and the lowest values in the basal ganglia and cerebellum. It should be real ized, however, that the interregional Bmax differ ences within the cortex might be due, at least in part, to a varying degree of white matter "contam ination." The equilibrium (or "dissociation") con stant K D is of the order of about 12 nM. No signif icant region-to-region variation or interindividual variations of K D were observed.
Only a very slight correlation between Bmax and K D was found. This correlation might be solely to progression of errors in the way Bmax and K D are calculated. In this context, note that the binding potential, the ratio of Bmax over K D , was found to be completely independent of the K D (see Fig. 6 ).
It should be noted that the equations used to cal culate Bmax and K D are ideal for pixel-by-pixel im
plementation. An example of such a calculation is shown in Fig. 7 , where Vd(O) and Vd(L) have been generated using the weighted integration method similar to that reported by Holthoff et al. (1991) . Applying Eqs. 12 and 13 on a pixel-by-pixel basis then produces images of Bmax, K D and binding po tential.
Other bolus injection methods
Steady-state conditions were not maintained in previous studies with e l C] flumazenil because non radioactive flu maze nil was administered by intrave nous bolus injection in the partial binding study. The resulting tracer curves have, in particular, been analyzed by the pseudoequilibrium approach, which is based on the finding of an almost-constant bound/ free ratio in the washout phase from the brain 20 to 50 min after injection (Pappata et aI., 1988) . Pappata et al. (1988) estimated the free concen tration of [ ll C]flumazenil in the cortex by perform ing a series of studies aimed at achieving full satu ration of receptors by nonradioactive flumazenil. This approach was considered valid because the plasma clearance curve of the tracer was found to be unaffected by the coinjected amount of nonra dioactive flumazenil. The technique is demanding, as at least three studies must be obtained in a given subject to calculate Bmax and Ko. Pappata et al. (1988) circumvented this problem by obtaining av erage curves in a group of normals, each being stud ied only twice, while Iyo et al. (1991) performed five tracer studies in the single normal subject they in vestigated. The full saturation approach suffers from three limitations. First, the free tracer concen tration in the cortex in studies with zero to moder ate occupancy will be higher in the washout phase than in a saturation study. Second, full saturation is difficult to reach and maintain. Third, the approach disregards the possibility of nonspecific binding of flumazenil in the brain by proteins and lipids, a phe nomenon known to occur in plasma. The fractional free concentration in the cortex can be estimated from theft>.. ratio as 0.64/0.79 = 0.81. This suggests that the error involved in neglecting nonspecific binding results in an overestimation of the free con centration by 19%. Persson et aL (1989) modified the pseudoequilib rium approach by taking the tracer concentration in a reference region with no receptors as the free con centration in the ROI. This approach has since also been used by Blomquist et aL (1990) and by , and it was analyzed in detail by Abadie et aL (1992) . The latter authors used three reference regions: the brain stem at the level of the pons, the corpus callosum, and the centrum semiovale. In the absence of an independent standard, they could not decide which one of the three gave the most cor rected data. The reference region approach suffers from several limitations. First, during the washout the free concentration of tracer in a receptor containing region will exceed that of a receptor-free region. Second, our studies and in vitro studies on rat brain slices (Mans et aI., 1992) , while pointing to an absence of receptors in the white matter, showed that the brain stem is not entirely free of receptors. Third, the influence of nonspecific binding in the reference regions, pons or white matter, must be taken into account, as it may not be the same as in the cortical regions. Fourth, the limited spatial res olution of PET causes difficulty in obtaining quan titative data from a structure as small as the brain stem.
A radically different mode of analysis based on nonlinear compartmental analysis taking into ac count the non-steady state was proposed by Blom quist et aL (1990) and also implemented by . This analyses was developed to its logical extreme by Delforges et aL (1993) , who carried out a complex multi-bolus-injection protocol in ba boons to calculate Ko as the KorlKon ratio of the receptor. However, the Koff ( = K _ \) of about 0.50 min -\ reported by Delforges et aL (1993) is practi- FIG. 7 . Example of functional flumazenil images. The Vd images have been produced using weighted integration (Holthoff et aI., 1991) and are scaled to the same maximum. These images were then used to generate B m ax, Ko, and binding potential images on a pixel-by-pixel basis.
cally the same as the washout rate of flumazenil from the cortex in the case of sudden complete re ceptor blockage: The estimated washout rate by blood flow assuming sudden complete displacement would, from our data, be k2 = K/>-.. = 0.40/0.79 = 0. 51 min -1. According to the model of Delforges et al. (1993) , an underestimation of Koff would tend to give proportional errors in Kon. Hence their ratio Ko' may well come close to the value obtained by using the opposite extreme, methodologically speaking, the steady-state approach. It will be in teresting to see results for Ko and Bmax in humans by the method of Delforges et aI. (1993) to check this prediction.
The results reported in the literature together with the present results are listed in Table 4 . The agreement is fair, considering the complex tech niques and different mathematical models used. In particular, the Ko values are fairly consistent be tween pseudoequilibrium and equilibrium studies.
For Bmax the pseudoequilibrium and nonequilibrium methods give somewhat lower values, however, on average 40% lower, than by the equilibrium ap proach. This suggests that the free concentration, taken in most studies to be that in the brain stem, overestimates the true value. 
Concluding comments on selection of method
The Bz receptor is heterogeneous since several subtypes exist as defined by differences in their af finities to various ligands (Costa, 1990; Guidotti et aI. , 1990; Ludden and Wisden, 1991) . This does not necessarily mean, however, that the Ko for fluma zenil varies over a wide range within a given ROI. Indeed, the finding of a straight line with a Scatch ard analysis using many datum points suggests min imal receptor Bz heterogeneity with respect to Ko (Pappata et al. , 1988; Johnson et al., 1990) . It is on this conceptual basis that the present method (and most of the other [ ll C] flumazenil methods) has been developed by requiring only two studies per sub ject, which is formally identical to drawing a line through only two points on a Scatchard plot.
Regarding the choice of method, if both Bmax and Ko are to be measured, then the steady-state ap proach, performing both unblocked and partially blocked studies in the same subject, is preferable. With this approach a 60-min scan time and single compartment analysis are preferable if multiple ar terial samples are taken. If only venous blood is sampled, then the integral approach using 120 min per study should be used. The steady-state ap proach can, however, also be implemented using (n = 5) (n = 2) (n = 4) (n = 6) (n = 2), this study (n = 8) , 20 min (n = 5), 25 min (n = 1), 25-40 min, frontal cortex Even though the steady-state approach is theo retically the best, one might in certain contexts pre fer the technically much simpler pseudoequilibrium method, despite the bias introduced by the various errors discussed above. Now we know that these errors are not gross and can estimate that, in all likelihood, the will tend to have the same direction and magnitude in many situations. The absolute val ues of Bmax and K D may be unimportant if the rel ative values can be relied upon to reveal differ ences. This would probably be the case if one were to study the Bz receptor as a function of age, in senile dementia, or in mental illnesses. In other sit uations, as in cerebrovascular disease, the steady state approach may well be a necessity for obtaining reliable values for interegional or interindividual comparison of Bmax and K D • Is it really necessary to determine both kinetic parameters? The present results, and those in the literature, suggest that K D is probably the same in all regions and that there are no significant interin dividual differences in the affinity of the receptor. This is indeed the result obtained in many in vitro studies of neuroreceptors in Alzheimer's disease as recently summarized by Nordberg (1992) : The con centration of receptors, Bmax, decreases, but the binding characteristics of the remaining receptors, the K D , appears to be unchanged. If this can be 77 47 13 7 (n = 2) (n = 4) assumed to be correct in a given context, then only one study per subject, a "tracer-alone" study, needs to be made, following the approach of Koeppe et al. (1991) . In that case the Bmax map may be calculated by mapping the binding potential, as suming that A. = 0.8 and f = 0.6, and then multi plying all pixels by the estimated K D , for which we suggest the use of a value of 12 nM.
APPENDIX
The fitting method to determine A. assumes that the interregional variation in both K D and A. is small. Although this is confirmed by the good fits obtained (Pig. 5) , small interregional variations cannot be ex cluded. The following simulation study was per formed to assess the effects of such variations.
The parameter values used in the simulations were based on their average values obtained in the present study: for Bmax the 15 values from Table 2 were useo (ex cluding white matter). In total, three simulations were performed:
(1) constant A. and variable Ko, (2) variable A. and constant Ko, and (3) both variable A. and variable Ko .
The variations of A. and K D were assumed to have a normal distribution around the above values with a variance of 10%. In each case Vd values were calculated using Eqs. 1, 2, and 10. }.. , Ko' and Bmax were then obtained in the usual way using Eqs. 15, 12, and 13, respectively. Each simulation was re peated 1,000 times. In Fig. AI, A2 , and A3 the mean values of these repeated simulations are given together with their standard deviations. The values for the brain stem, however, are not included in the plots, since standard deviations were more than 100%. Brain-stem Ko values for the three cases were -1.29 ± 1.72, 1.13 ± 1.29, and -1.18 ± 2.27, respectively. Bmax values were 1.01 ± 2.28, 1.82 ± 1.86, and 1.83± 3.68, respectively. The main reason for this is an overestimation of the fitted value of }.. (0.89, compared to the true value of 0.80). Figure A3 shows the same trend, but with higher standard deviations due to the addi- The reason for the bias due to variations in Ko is the nonlinear relationship among Ko' Bmax, and Yd.
The linear regression to obtain }.. is biased toward high Bmax values (Fig. 5) , a bias that was repro duced in the simulation study. The net result of this bias is an overestimation of }.. , with subsequent un derestimations of Bmax and Ko. This finding was confirmed with an additional simulation study using a more even distribution of Bmax values, which re sulted in a more accurate determination of }.. and, therefore, of B max and Ko. Further studies are re quired to determine the optimal selection of regions for the determination of }.. in practice, taking into account that white matter should be avoided.
